Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa Rollins

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Plos Medicine|December 31, 2005
An alternative and effective HIV vaccination approach based on inhibition of antigen presentation attenuators in dendritic cellsXiao-Tong Song, Kevin Evel-Kabler, Lisa Rollins, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2003
Human telomerase reverse transcriptase-specific T-helper responses induced by promiscuous major histocompatibility complex class II-restricted epitopesRoland Schroers, Lei Shen, Lisa Rollins, et al.
Cancer Research|November 13, 2003
A broadly applicable, personalized heat shock protein-mediated oncolytic tumor vaccineXue F Huang, Wenhong Ren, Lisa Rollins, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 21, 2010
A Th1-inducing adenoviral vaccine for boosting adoptively transferred T cellsXiao-Tong Song, Meghan E Turnis, Xiaoou Zhou, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 21, 2011
PiggyBac-mediated cancer immunotherapy using EBV-specific cytotoxic T-cells expressing HER2-specific chimeric antigen receptorYozo Nakazawa, Leslie E Huye, Vita S Salsman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 28, 2017
Comprehensive Approach for Identifying the T Cell Subset Origin of CD3 and CD28 Antibody-Activated Chimeric Antigen Receptor-Modified T CellsMichael Schmueck-Henneresse, Bilal Omer, Thomas Shum, et al.
JCI Insight|February 9, 2018
Efficacy of intracellular immune checkpoint-silenced DC vaccineDanhong Wang, Xue F Huang, Bangxing Hong, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Plos Medicine|December 31, 2005
An alternative and effective HIV vaccination approach based on inhibition of antigen presentation attenuators in dendritic cellsXiao-Tong Song, Kevin Evel-Kabler, Lisa Rollins, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2003
Human telomerase reverse transcriptase-specific T-helper responses induced by promiscuous major histocompatibility complex class II-restricted epitopesRoland Schroers, Lei Shen, Lisa Rollins, et al.
Cancer Research|November 13, 2003
A broadly applicable, personalized heat shock protein-mediated oncolytic tumor vaccineXue F Huang, Wenhong Ren, Lisa Rollins, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 21, 2010
A Th1-inducing adenoviral vaccine for boosting adoptively transferred T cellsXiao-Tong Song, Meghan E Turnis, Xiaoou Zhou, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 21, 2011
PiggyBac-mediated cancer immunotherapy using EBV-specific cytotoxic T-cells expressing HER2-specific chimeric antigen receptorYozo Nakazawa, Leslie E Huye, Vita S Salsman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 28, 2017
Comprehensive Approach for Identifying the T Cell Subset Origin of CD3 and CD28 Antibody-Activated Chimeric Antigen Receptor-Modified T CellsMichael Schmueck-Henneresse, Bilal Omer, Thomas Shum, et al.
JCI Insight|February 9, 2018
Efficacy of intracellular immune checkpoint-silenced DC vaccineDanhong Wang, Xue F Huang, Bangxing Hong, et al.
Pageof 2